347 250
Pill imprint 347 250 has been identified as Cefprozil 250 mg.
Cefprozil is used in the treatment of sinusitis; bladder infection; upper respiratory tract infection; kidney infections; tonsillitis/pharyngitis (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy.
Cefprozil 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Cefprozil Images
- Imprint:
-
347
250 - Strength:
- 250 mg
- Color:
- White
- Size:
- 14.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose
magnesium stearate
methylcellulose
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
sodium starch glycolate
titanium dioxide
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-5043
Advertisement
More Cefprozil resources
- Cefprozil (Wolters Kluwer)
- Cefprozil Suspension (Wolters Kluwer)
- cefprozil (Cerner Multum)
- cefprozil (Micromedex) - Includes Dosage Information
- Cefprozil (AHFS DI)
- Cefprozil (FDA)
- Cefprozil Tablets (FDA)
- Cefprozil (Wolters Kluwer)
Search Again
